Low Vitamin D: Higher Levels Tied to Fewer Cancer Deaths
Graded Moderate — a UK Biobank analysis that mimics two large vitamin D trials on paper; it measured existing blood levels rather than randomly assigned pills, so cause cannot be shown.
- Design
- Prospective cohort study
- Participants
- —
- Duration
- —
- Funding
- China Scholarship Council
Among people low in vitamin D, higher blood levels went along with a lower risk of dying from cancer.
Two large trials gave people either vitamin D or a dummy pill, chosen at random. Neither found fewer cancer cases or cancer deaths. But most participants in those trials already had enough vitamin D in their blood. A new analysis of British health data hints that the picture may differ for people who are low. Among them, higher vitamin D levels went along with fewer deaths from cancer.
The team used the UK Biobank, a large British health study. They picked people who met the entry rules of the two trials, called VITAL and D-Health. Then they asked what the rise in blood levels seen in those trials would mean. When blood levels looked like those in the trials, there was no link with cancer. In people with severe deficiency, the risk of dying from cancer was 13 percent lower. In milder deficiency it was 7 to 8 percent lower, though one of the two estimates showed no clear difference.
The study compared the vitamin D levels people already had, not whether they took supplements. So it cannot show that pills prevent cancer deaths in people who are low. The authors conclude the trials' null results were to be expected, because few participants were deficient.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
